| Predicate | Object |
|---|---|
| rdf:type | |
| entrezgene:geneRifText |
Results indicate that pharmacogenetic testing for VKORC1*2, CYP2C9*2 and CYP2C9*3 polymorphisms is more informative regarding warfarin dose requirements than testing for VKORC1*3, VKORC1*4, and CYP4F2 (1347 C > T) polymorphisms.
|